Trial Profile
A Phase 1 Study to Determine the Single and Repeat Dose Pharmacokinetics, Food Effect, Proton Pump Inhibitor PPI Drug Interaction, Safety and Tolerability of Oral Prototype Formulations of BOS172767 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Nov 2018
Price :
$35
*
At a glance
- Drugs SLX 0528 (Primary)
- Indications Autoimmune disorders; Multiple sclerosis; Psoriasis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Boston Pharmaceuticals
- 01 Nov 2018 Status changed from recruiting to completed.
- 20 Mar 2018 New trial record